International buyers need to separate a licensed UK supply route from an overseas exporter offering stock into England. By checking the product’s 25mg identity, MHRA status, supplier role, batch documents and transport conditions, you can decide whether a quotation represents lawful, usable supply rather than a brand name alone.
Key takeaways
- Verify the supplier’s current MHRA WDA(H) before ordering.
- Confirm the quotation names lenalidomide 25mg capsules, not another strength or form.
- Request batch, certificate and transport documents before committing to bulk supply.
- Compare Incoterms, storage conditions and delivery responsibility across quotations.
Start with the UK authorisation and the supplier’s legal role
A proposed source is authorised only when both the medicine and the supplying business withstand separate checks. For a UK wholesaler handling finished lenalidomide capsules, request its current Wholesale Dealer’s Authorisation (Human), or WDA(H), and verify the licence through the MHRA.
Check its GDP arrangements and confirm that the legal entity named on the quotation holds the authorisation.
Do not treat a claim such as “lenalid 25mg capsules supplier in england” as proof of legal status. The advertiser may be a broker. Identify the entity that will invoice you, import the stock, release it, store it and deliver it; different companies may perform those functions, and each role needs verification.
Check the exact product in the MHRA medicines database and compare it with the NHS dm+d. Confirm the product name, 25 mg strength, capsule form, marketing-authorisation holder and UK authorisation number. A brand approval or manufacturing licence from India does not replace a Great Britain marketing authorisation.
UK availability also means more than a database entry: authorised stock can be unavailable, while imported or unlicensed stock can appear in a wholesaler’s catalogue.
Before treating any “lenalidomide 25mg supplier uk” as suitable, ask for:
- The WDA(H) number and licensed premises address.
- The product’s MHRA record and current stock location.
- The importer's identity and legal route into England.
- The supplier’s procedure for prescription-only supply and lenalidomide risk controls, including pregnancy testing, contraception advice, and blood and semen donation restrictions.
A website offering direct, non-prescription sales is a disqualifying warning sign.
Separate domestic UK availability from export stock entering England
A capsule available for UK dispensing has a Great Britain marketing authorisation, an identifiable UK presentation and a supply route through the licensed entity responsible for wholesale, storage and delivery. Export stock entering England may be genuine medicine, yet intended for another country and not authorised for routine dispensing to UK patients.
Search “lenalidomide capsules uk availability” in both the MHRA medicines database and NHS dm+d. An authorisation does not prove current wholesaler stock, while a wholesaler listing can represent imported or unlicensed stock rather than a routinely authorised UK presentation.
| Supply route | What you should see | Main implication |
|---|---|---|
| Domestic UK dispensing stock | Exact product name, 25mg strength, pharmaceutical form, marketing-authorisation holder and UK authorisation number; stock held by a licensed UK wholesaler | Suitable for UK dispensing when the prescription, risk controls and supply permissions are satisfied |
| Export stock entering England | Overseas brand or presentation, foreign market documents, an identified importer and evidence of MHRA import, quality and release arrangements | Not automatically lawful for UK dispensing; a UK relabel or English warehouse address does not create a UK authorisation |
Ask who owns the stock, where it is physically held, and which entity will invoice, import, release, store and deliver it. A broker may perform none of these functions.
Lenalidomide also carries pregnancy-prevention, contraception, and blood and semen donation controls. A credible distributor must explain how those controls operate at dispensing and distribution level, not merely provide an Indian manufacturing approval.
Prove that the quotation is for 25mg capsules
Do not accept “Lenalid 25 bulk supply” as proof of strength. Ask for clear photographs or a verbatim transcription of the outer carton, blister foil and capsule marking. Each must identify lenalidomide and 25 mg; a quotation showing only “Lenalid” leaves the 15 mg presentation unresolved.
Request these records for the exact batch offered:
- Product name, strength, capsule form and pack configuration
- Batch number, expiry date at dispatch and release certificate
- Certificate of analysis matching that batch and confirming the 25 mg assay
- Approved product information or artwork showing the same carton and blister wording
- Storage statement, including storage below 25°C where specified
- Manufacturer, importer and batch-release entity
Compare the physical and documentary evidence before paying:
| Presentation | Physical confirmation | Documentary confirmation |
|---|---|---|
| 25 mg capsule | Carton and blister state “lenalidomide 25 mg”; capsule marking matches the approved artwork | Quotation, product specification, release certificate and certificate of analysis all state 25 mg |
| 15 mg capsule | Any carton, blister or capsule marking states “15 mg” | Batch documents identify a 15 mg presentation, regardless of the quoted price |
| Unidentified product | Labels omit the strength, disagree, or show a different name or batch | Documents cannot link the offered batch to an authorised product record |
Check that the batch number and expiry match across carton, blister, certificate of analysis and release certificate. If the photographs show 25 mg but the documents say 15 mg, or the strength appears only on an altered quotation, stop the order and request corrected evidence.
Request the compliance file before placing a bulk order
Before approving lenalid 25 bulk supply, require a compliance file for the exact manufacturer, importer, wholesaler and stock location. A broker’s brochure or overseas GMP certificate does not prove that the contracting party can lawfully store, release or supply prescription-only medicine in England.
Request these records:
- The UK wholesaler’s current Wholesale Dealer’s Authorisation (Human), or WDA(H), and its GDP certificate or latest inspection evidence. Verify the licence number against the MHRA register.
- The product’s UK marketing authorisation details, approved product information and manufacturer or importer name. Record the batch-release site and confirm whether an authorised person releases each batch.
- A recent certificate of analysis, batch release certificate, batch number, expiry date, carton and blister photographs, pack configuration and written storage condition: below 25°C where specified.
- Temperature-monitoring records for storage and transit, the transport company’s controls, recall procedure and named pharmacovigilance or quality contact.
- Evidence that dispensing and distribution support lenalidomide risk controls, including pregnancy testing, contraception advice, and restrictions on blood and semen donation.
- A quotation, pro forma invoice, commercial invoice, Incoterms rule, payment terms, delivery address and statement identifying who imports, clears customs and bears damage or temperature-excursion risk.
| Document or evidence | What it confirms | Reject the file when |
|---|---|---|
| WDA(H) and GDP evidence | The England-based wholesaler’s legal role and distribution controls | The seller supplies only a company registration |
| Marketing authorisation and product information | The medicine’s UK regulatory status and 25mg presentation | The supplier provides only an overseas GMP certificate |
| Batch certificate and temperature records | The offered stock’s identity, quality and handling | Batch, expiry or storage data are missing |
| Invoice and Incoterms | Who contracts, imports and accepts delivery risk | A broker will not name the licensed seller |
A credible lenalid capsules distributor in england can identify each responsible entity without hesitation.
Compare quotations by storage, transport and delivery responsibility
The lowest unit price is not the safer route if nobody accepts responsibility for temperature excursions, customs release or a damaged shipment. Compare the physical stock location and legal role behind every “lenalid 25mg capsules supplier in england” result: a broker may arrange the sale while another company imports, stores and delivers it.
| Comparison point | England-based distributor | Exporter supplying into England |
|---|---|---|
| Stock and storage | Confirm the warehouse address, batch, expiry and storage below 25°C | Confirm who receives the goods, where they are stored and who records temperature |
| Transport | Request GDP transport arrangements, excursion handling and delivery proof | Confirm the carrier, temperature controls, customs route and insurance |
| Legal responsibility | Identify the WDA(H) holder invoicing, releasing and supplying the medicine | Identify the importer, UK release entity and party responsible for defects or recall |
| Delivery terms | Check whether delivery ends at your named site or a UK depot | Reject vague “delivered” wording; record the agreed Incoterm, customs payer and handover point |
Treat “lenalidomide 25mg supplier uk” and “lenalidomide capsules uk availability” as search terms, not evidence of stock or authority. Ask for the quotation to name the exact presentation, pack configuration, expiry at dispatch, batch documents, recall contact and delivery temperature record.
If NIBA HEALTHCARE quotes as an exporter, compare its named importing and delivery partners against a UK wholesaler with a current WDA(H), rather than assuming an England address transfers responsibility. The safer choice is the route that assigns each handover in writing and leaves one identifiable party accountable for storage, transport, release and recall.
Related product
 | LENALIDOMIDE CAPSULES Lenalid 15 Capsule belongs to a group of medicines that affect how your immune system works. View product → |
Frequently asked questions
What UK authorisation should an England-based wholesaler provide?
Ask for the supplier’s current Wholesale Dealer’s Authorisation (Human), or WDA(H), then verify the licence through the MHRA. Check that its scope covers wholesale dealing in human medicines.
Does stock in England prove domestic UK availability?
No. Ask whether the stock is authorised for the UK market or held for export. Request the product’s market, marketing authorisation details and destination restrictions before treating it as UK availability.
How can buyers confirm they are ordering lenalidomide 25mg capsules?
Require the quotation and pro forma invoice to state lenalidomide, 25mg strength, capsules, pack size, manufacturer, batch or expected batch details and expiry period.
Which compliance documents should buyers request before a bulk order?
Request the WDA(H) copy, product authorisation information, certificate of analysis, batch details, expiry date, packaging photographs or artwork, storage requirements and shipping documentation.
